Article Abstract

Liver resection for multifocal hepatocellular carcinoma: is it an option?

Authors: Luca Viganò, Guido Costa, Luca Di Tommaso

Abstract

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. At first diagnosis, HCC is multifocal in about 35–40% of patients (1,2). According to Western guidelines, the treatment of multifocal (non-metastatic) HCC is well codified: transplantation is indicated for HCCs within Milan criteria (2–3 nodules ≤30 mm), ablation for non-transplantable HCCs within Milan criteria, and chemoembolization for the remaining patients (3). Liver resection has no role. Daily practice is much more complex. The term multinodular HCC encompasses a wide range of scenarios, from oligonodular to diffuse disease, from multicentric to metastatic tumors, that require a case-by-case tailored treatment. We are still far from a real solution and several issues deserve further investigations, including the role of surgery, as highlighted by the recently published Japanese series of liver resections for multiple HCCs (1).

Article Options

Download Citation